Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 43, Issue 6, Pages 1320-1331
Publisher
Wiley
Online
2023-04-03
DOI
10.1111/liv.15566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
- (2022) James Yarmolinsky et al. PLOS MEDICINE
- Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation
- (2022) Anubha Mahajan et al. NATURE GENETICS
- Hepatocellular carcinoma
- (2022) Arndt Vogel et al. LANCET
- Multiomics study of nonalcoholic fatty liver disease
- (2022) Gardar Sveinbjornsson et al. NATURE GENETICS
- Using human genetics to improve safety assessment of therapeutics
- (2022) Keren J. Carss et al. NATURE REVIEWS DRUG DISCOVERY
- Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study
- (2022) Paweł Rajewski et al. Journal of Clinical Medicine
- Antihypertensive Therapy and Incidence of Cancer
- (2022) Sven H. Loosen et al. Journal of Clinical Medicine
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
- (2021) Sirui Zhou et al. NATURE MEDICINE
- The use of two-sample methods for Mendelian randomization analyses on single large datasets
- (2021) Cosetta Minelli et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
- (2021) Emma Copland et al. LANCET ONCOLOGY
- Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
- (2021) Raha Pazoki et al. Nature Communications
- Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy
- (2020) Maria Lukács Krogager et al. HYPERTENSION
- Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
- (2020) Kazuyoshi Ishigaki et al. NATURE GENETICS
- Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study
- (2020) Kwang Min Kim et al. Clinics and Research in Hepatology and Gastroenterology
- Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma
- (2020) Su Zhang et al. CANCER LETTERS
- Meta-Analysis and Mendelian randomization: A review
- (2019) Jack Bowden et al. Research Synthesis Methods
- Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
- (2019) Guillermo Prada-Ramallal et al. BMC Medical Research Methodology
- Factorial Mendelian randomization: using genetic variants to assess interactions
- (2019) Jessica M B Rees et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
- (2019) Venexia M Walker et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Nonalcoholic Fatty Liver Disease
- (2019) Yan-Ci Zhao et al. HYPERTENSION
- β-blockers: Their new life from hypertension to cancer and migraine
- (2019) Carlo Fumagalli et al. PHARMACOLOGICAL RESEARCH
- Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio
- (2018) Luke R. Lloyd-Jones et al. GENETICS
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Publisher Correction: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
- (2018) Marie Verbanck et al. NATURE GENETICS
- Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases
- (2018) Masahiro Kanai et al. NATURE GENETICS
- Transformation of Summary Statistics from Linear Mixed Model Association on All-or-None Traits to Odds Ratio
- (2018) Luke R. Lloyd-Jones et al. GENETICS
- Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry
- (2018) Loic Yengo et al. HUMAN MOLECULAR GENETICS
- Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
- (2018) Evangelos Evangelou et al. NATURE GENETICS
- Genome-wide association study identifies 112 new loci for body mass index in the Japanese population
- (2017) Masato Akiyama et al. NATURE GENETICS
- Antihypertensive drugs
- (2017) Stéphane Laurent PHARMACOLOGICAL RESEARCH
- Orienting the causal relationship between imprecisely measured traits using GWAS summary data
- (2017) Gibran Hemani et al. PLoS Genetics
- Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease
- (2017) Pim van der Harst et al. CIRCULATION RESEARCH
- Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity
- (2016) Stefano Taddei et al. American Journal of Cardiovascular Drugs
- Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies
- (2016) Philip C Haycock et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- PhenoScanner: a database of human genotype–phenotype associations
- (2016) James R. Staley et al. BIOINFORMATICS
- Beta blockers and cancer prognosis – The role of immortal time bias: A systematic review and meta-analysis
- (2016) Janick Weberpals et al. CANCER TREATMENT REVIEWS
- Bias due to participant overlap in two-sample Mendelian randomization
- (2016) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
- (2016) Gennaro D'Amico et al. HEPATOLOGY
- Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the UK Clinical Practice Research Datalink
- (2016) Katrina Wilcox Hagberg et al. PHARMACOTHERAPY
- Thiazide Diuretics in Chronic Kidney Disease
- (2015) Arjun D. Sinha et al. CURRENT HYPERTENSION REPORTS
- Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials
- (2015) Maja Thiele et al. LIVER INTERNATIONAL
- Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis
- (2014) Alejandro González-Ojeda WORLD JOURNAL OF GASTROENTEROLOGY
- Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis
- (2014) Xing-Shun Qi WORLD JOURNAL OF GASTROENTEROLOGY
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
- (2014) Claudia Giambartolomei et al. PLoS Genetics
- Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis
- (2013) Chad McKee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice
- (2010) Chiyo Doi et al. BMC CANCER
- Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells
- (2010) Lara Pickel et al. CANCER BIOLOGY & THERAPY
- Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites
- (2010) Thomas Sersté et al. HEPATOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started